Pancreatic Cancer Research

ResearcherUniversitat de GironaNo recent work listed

Esther Llop Escorihuela

Matched on ORCID iD 0000-0003-0929-4888; OpenAlex author ID A5083999714. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers

Papers 10

  1. Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients' Sera. Co-author DOI 10.3390/biomedicines10081942↗
  2. Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in… Co-author DOI 10.3390/cancers14246133↗
  3. Microfibril associated protein 4 (MFAP4) is a carrier of the tumor associated carbohydrate sialyl-Lewis x (sLe x) in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.jprot.2020.104004↗
  4. Knockdown of α2,3-Sialyltransferases Impairs Pancreatic Cancer Cell Migration, Invasion and E-selectin-Dependent Adhesion. Co-author DOI 10.3390/ijms21176239↗
  5. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues. Co-author DOI 10.1016/j.ijbiomac.2018.01.148↗
  6. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.3748/wjg.v24.i24.2537↗
  7. Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer. Co-author DOI 10.1016/j.jprot.2015.11.006↗
  8. Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin. Co-author DOI 10.1016/j.cca.2015.01.007↗
  9. Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer… Co-author DOI 10.1016/j.cyto.2015.04.006↗
  10. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarci… Co-author DOI 10.1016/j.biocel.2013.05.015↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rosa Peracaula Miró · 10 shared papers, 2013–2022 · strength 0.91
  2. Pedro Enrique Guerrero · 5 shared papers, 2018–2022 · strength 0.64
  3. Adrià Duran · 4 shared papers, 2018–2022 · strength 0.46
  4. Adelaida Garcia-Velasco · 2 shared papers, 2021–2022 · strength 0.29
  5. Laura Miró · 2 shared papers, 2020–2022 · strength 0.26
  6. Neus Martínez‐Bosch · 2 shared papers, 2020–2022 · strength 0.26
  7. Pilar Navarro · 2 shared papers, 2020–2022 · strength 0.26
  8. Meritxell Balmaña · 3 shared papers, 2015–2018 · strength 0.18
  9. María José Ferri · 3 shared papers, 2013–2018 · strength 0.16
  10. Noemí Manero‐Rupérez · 1 shared paper, 2022 · strength 0.15
  11. Κωνσταντίνος Κωνσταντόπουλος · 1 shared paper, 2020 · strength 0.11
  12. Bin Sheng Wong · 1 shared paper, 2020 · strength 0.11
  13. Celso Albuquerque Reis · 1 shared paper, 2018 · strength 0.08
  14. Sònia Bassagañas · 1 shared paper, 2015 · strength 0.06
  15. Victòria Sanz‐Nebot · 1 shared paper, 2016 · strength 0.05
  16. Marta Pérez-Garay · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.